Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes.

Wadowski PP, Weikert C, Pultar J, Lee S, Eichelberger B, Koppensteiner R, Lang IM, Panzer S, Gremmel T.

Cardiovasc Drugs Ther. 2020 Feb 15. doi: 10.1007/s10557-019-06932-7. [Epub ahead of print]

PMID:
32062795
2.

Associations of a vegan diet with inflammatory biomarkers.

Menzel J, Biemann R, Longree A, Isermann B, Mai K, Schulze MB, Abraham K, Weikert C.

Sci Rep. 2020 Feb 6;10(1):1933. doi: 10.1038/s41598-020-58875-x.

3.

Sublingual microvasculature in diabetic patients.

Wadowski PP, Kautzky-Willer A, Gremmel T, Koppensteiner R, Wolf P, Ertl S, Weikert C, Schörgenhofer C, Jilma B.

Microvasc Res. 2019 Dec 30;129:103971. doi: 10.1016/j.mvr.2019.103971. [Epub ahead of print]

PMID:
31899168
4.

Associations between Dietary Patterns and Bile Acids-Results from a Cross-Sectional Study in Vegans and Omnivores.

Trefflich I, Marschall HU, Giuseppe RD, Ståhlman M, Michalsen A, Lampen A, Abraham K, Weikert C.

Nutrients. 2019 Dec 23;12(1). pii: E47. doi: 10.3390/nu12010047.

5.

Is a vegan or a vegetarian diet associated with the microbiota composition in the gut? Results of a new cross-sectional study and systematic review.

Trefflich I, Jabakhanji A, Menzel J, Blaut M, Michalsen A, Lampen A, Abraham K, Weikert C.

Crit Rev Food Sci Nutr. 2019 Oct 21:1-15. doi: 10.1080/10408398.2019.1676697. [Epub ahead of print]

PMID:
31631671
6.

Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors.

Wadowski PP, Pultar J, Weikert C, Eichelberger B, Panzer B, Huber K, Lang IM, Koppensteiner R, Panzer S, Gremmel T.

Res Pract Thromb Haemost. 2019 May 22;3(3):383-390. doi: 10.1002/rth2.12213. eCollection 2019 Jul.

7.

Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction, and Stroke: A Prospective Cohort Study.

Aleksandrova K, Drogan D, Weikert C, Schulze MB, Fritsche A, Boeing H, Pischon T.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):5991-6002. doi: 10.1210/jc.2019-00477.

PMID:
31211381
8.

Functional capillary impairment in patients with ventricular assist devices.

Wadowski PP, Steinlechner B, Zimpfer D, Schlöglhofer T, Schima H, Hülsmann M, Lang IM, Gremmel T, Koppensteiner R, Zehetmayer S, Weikert C, Pultar J, Jilma B.

Sci Rep. 2019 Apr 11;9(1):5909. doi: 10.1038/s41598-019-42334-3.

9.

Association of Chemerin Plasma Concentration With Risk of Colorectal Cancer.

Eichelmann F, Schulze MB, Wittenbecher C, Menzel J, Weikert C, di Giuseppe R, Biemann R, Isermann B, Fritsche A, Boeing H, Aleksandrova K.

JAMA Netw Open. 2019 Mar 1;2(3):e190896. doi: 10.1001/jamanetworkopen.2019.0896.

10.

Methionine restriction prevents onset of type 2 diabetes in NZO mice.

Castaño-Martinez T, Schumacher F, Schumacher S, Kochlik B, Weber D, Grune T, Biemann R, McCann A, Abraham K, Weikert C, Kleuser B, Schürmann A, Laeger T.

FASEB J. 2019 Jun;33(6):7092-7102. doi: 10.1096/fj.201900150R. Epub 2019 Mar 6.

11.

Energy Drinks Induce Acute Cardiovascular and Metabolic Changes Pointing to Potential Risks for Young Adults: A Randomized Controlled Trial.

Basrai M, Schweinlin A, Menzel J, Mielke H, Weikert C, Dusemund B, Putze K, Watzl B, Lampen A, Bischoff SC.

J Nutr. 2019 Mar 1;149(3):441-450. doi: 10.1093/jn/nxy303.

PMID:
30805607
12.

Chemerin as a Biomarker Linking Inflammation and Cardiovascular Diseases.

Eichelmann F, Schulze MB, Wittenbecher C, Menzel J, Weikert C, di Giuseppe R, Biemann R, Isermann B, Fritsche A, Boeing H, Aleksandrova K.

J Am Coll Cardiol. 2019 Jan 29;73(3):378-379. doi: 10.1016/j.jacc.2018.10.058. No abstract available.

13.

Breastfeeding Rates and Programs in Europe: A Survey of 11 National Breastfeeding Committees and Representatives.

Theurich MA, Davanzo R, Busck-Rasmussen M, Díaz-Gómez NM, Brennan C, Kylberg E, Bærug A, McHugh L, Weikert C, Abraham K, Koletzko B.

J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):400-407. doi: 10.1097/MPG.0000000000002234.

PMID:
30562307
14.

Diet-quality scores and the risk of symptomatic gallstone disease: a prospective cohort study of male US health professionals.

Wirth J, Song M, Fung TT, Joshi AD, Tabung FK, Chan AT, Weikert C, Leitzmann M, Willett WC, Giovannucci E, Wu K.

Int J Epidemiol. 2018 Dec 1;47(6):1938-1946. doi: 10.1093/ije/dyy210.

15.

[Becoming breastfeeding friendly in Germany-an international research project to assess the readiness to scale up breastfeeding].

Flothkötter M, Kunath J, Lücke S, Reiss K, Menzel J, Weikert C.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):1012-1021. doi: 10.1007/s00103-018-2784-1. German.

PMID:
30014189
16.

[Is breastfeeding in public socially accepted? : Experiences and attitudes of the general population and breastfeeding mothers].

Koch S, Abraham K, Sievers E, Epp A, Lohmann M, Böl GF, Weikert C.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):990-1000. doi: 10.1007/s00103-018-2785-0. Review. German.

PMID:
29987500
17.

Nordic diet, Mediterranean diet, and the risk of chronic diseases: the EPIC-Potsdam study.

Galbete C, Kröger J, Jannasch F, Iqbal K, Schwingshackl L, Schwedhelm C, Weikert C, Boeing H, Schulze MB.

BMC Med. 2018 Jun 27;16(1):99. doi: 10.1186/s12916-018-1082-y.

18.

[Breastfeeding rate and promotion in selected European countries].

Theurich MA, Weikert C, Abraham K, Koletzko B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):926-936. doi: 10.1007/s00103-018-2762-7. Review. German.

PMID:
29943261
19.

[Monitoring breastfeeding in Germany-the current need for action and perspectives].

Sievers E, Weikert C, Weißenborn A, Kersting M.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):911-919. doi: 10.1007/s00103-018-2772-5. Review. German.

PMID:
29943260
20.

[Xenobiotics and pathogens in breast milk : A risk for the child?]

Padberg S, Bührer C, Menzel J, Weikert C, Schaefer C, Abraham K.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Aug;61(8):960-970. doi: 10.1007/s00103-018-2764-5. Review. German.

PMID:
29934679
21.

[Assessing incident cardiovascular and metabolic diseases in epidemiological cohort studies in Germany].

Herrmann WJ, Weikert C, Bergmann M, Boeing H, Katzke VA, Kaaks R, Tiller D, Greiser KH, Heier M, Meisinger C, Schmidt CO, Neuhauser H, Heidemann C, Jünger C, Wild PS, Schramm SH, Jöckel KH, Dörr M, Pischon T.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Apr;61(4):420-431. doi: 10.1007/s00103-018-2712-4. German.

PMID:
29487975
22.

[Musical Inactivity - A Risk Factor? A Short Questionnaire to Assess Musical Activity (MusA)].

Fernholz I, Menzel J, Jabusch HC, Gembris H, Fischer F, Kendel F, Kreutz G, Schmidt A, Willich SN, Weikert C.

Gesundheitswesen. 2019 Nov;81(11):907-910. doi: 10.1055/s-0044-101143. Epub 2018 Feb 27. German.

PMID:
29486500
23.

The cross-sectional association between chemerin and bone health in peri/pre and postmenopausal women: results from the EPIC-Potsdam study.

Menzel J, Biemann R, Aleksandrova K, Schulze MB, Boeing H, Isermann B, Weikert C.

Menopause. 2018 May;25(5):574-578. doi: 10.1097/GME.0000000000001041.

24.

Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.

Floegel A, Kühn T, Sookthai D, Johnson T, Prehn C, Rolle-Kampczyk U, Otto W, Weikert C, Illig T, von Bergen M, Adamski J, Boeing H, Kaaks R, Pischon T.

Eur J Epidemiol. 2018 Jan;33(1):55-66. doi: 10.1007/s10654-017-0333-0. Epub 2017 Nov 27.

25.

Decreased platelet inhibition by P2Y12 receptor blockers in anaemia.

Wadowski PP, Kopp CW, Koppensteiner R, Lang IM, Pultar J, Lee S, Weikert C, Panzer S, Gremmel T.

Eur J Clin Invest. 2018 Jan;48(1). doi: 10.1111/eci.12861. Epub 2017 Dec 7.

PMID:
29171876
26.

Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study.

Menzel J, di Giuseppe R, Biemann R, Wittenbecher C, Aleksandrova K, Eichelmann F, Fritsche A, Schulze MB, Boeing H, Isermann B, Weikert C.

Sci Rep. 2017 Oct 26;7(1):14171. doi: 10.1038/s41598-017-14518-2.

27.

Methodological utility of chemerin as a novel biomarker of immunity and metabolism.

Eichelmann F, Weikert C, di Giuseppe R, Biemann R, Isermann B, Schulze MB, Boeing H, Aleksandrova K.

Endocr Connect. 2017 Jul;6(5):340-347. doi: 10.1530/EC-17-0098. Epub 2017 Jun 7.

28.

Multiple imputation was a valid approach to estimate absolute risk from a prediction model based on case-cohort data.

Mühlenbruch K, Kuxhaus O, di Giuseppe R, Boeing H, Weikert C, Schulze MB.

J Clin Epidemiol. 2017 Apr;84:130-141. doi: 10.1016/j.jclinepi.2016.12.019. Epub 2017 Jan 28.

29.

Hypertension in Germany.

Neuhauser H, Diederichs C, Boeing H, Felix SB, Jünger C, Lorbeer R, Meisinger C, Peters A, Völzke H, Weikert C, Wild P, Dörr M.

Dtsch Arztebl Int. 2016 Dec 2;113(48):809-815. doi: 10.3238/arztebl.2016.0809.

30.

Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.

Wirth J, Atzler D, di Giuseppe R, Cordts K, Menzel J, Böger RH, Boeing H, Weikert C, Schwedhelm E.

Amino Acids. 2017 Jan;49(1):173-182. doi: 10.1007/s00726-016-2348-3. Epub 2016 Oct 28.

PMID:
27796501
31.

Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator.

Menzel J, Di Giuseppe R, Biemann R, Aleksandrova K, Kuxhaus O, Wittenbecher C, Fritsche A, Schulze MB, Isermann B, Boeing H, Weikert C.

J Endocrinol Invest. 2016 Nov;39(11):1347-1355. Epub 2016 Sep 10.

32.

A Mediterranean-style diet, its components and the risk of heart failure: a prospective population-based study in a non-Mediterranean country.

Wirth J, di Giuseppe R, Boeing H, Weikert C.

Eur J Clin Nutr. 2016 Sep;70(9):1015-21. doi: 10.1038/ejcn.2016.140. Epub 2016 Aug 10.

PMID:
27507073
33.

Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial.

Biemann R, Penner M, Borucki K, Westphal S, Luley C, Rönicke R, Biemann K, Weikert C, Lux A, Goncharenko N, Marschall HU, Schneider JG, Isermann B.

Sci Rep. 2016 Jul 25;6:30173. doi: 10.1038/srep30173.

34.

Evaluating dietary patterns: the role of reduced rank regression.

Weikert C, Schulze MB.

Curr Opin Clin Nutr Metab Care. 2016 Sep;19(5):341-346. doi: 10.1097/MCO.0000000000000308.

PMID:
27389081
35.

Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study.

di Giuseppe R, Biemann R, Wirth J, Menzel J, Isermann B, Stangl GI, Fritsche A, Boeing H, Schulze MB, Weikert C.

Eur J Epidemiol. 2017 Feb;32(2):113-123. doi: 10.1007/s10654-016-0172-4. Epub 2016 Jun 15.

PMID:
27307249
36.

Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.

Menzel J, di Giuseppe R, Biemann R, Wittenbecher C, Aleksandrova K, Pischon T, Fritsche A, Schulze MB, Boeing H, Isermann B, Weikert C.

Atherosclerosis. 2016 Aug;251:415-421. doi: 10.1016/j.atherosclerosis.2016.06.003. Epub 2016 Jun 2.

37.

Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort study.

Muller DC, Murphy N, Johansson M, Ferrari P, Tsilidis KK, Boutron-Ruault MC, Clavel F, Dartois L, Li K, Kaaks R, Weikert C, Bergmann M, Boeing H, Tjønneland A, Overvad K, Redondo ML, Agudo A, Molina-Portillo E, Altzibar JM, Cirera L, Ardanaz E, Khaw KT, Wareham NJ, Key TJ, Travis RC, Bamia C, Orfanos P, Trichopoulou A, Palli D, Pala V, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Verschuren WM, Struijk EA, Peeters PH, Engström G, Melander O, Sund M, Weiderpass E, Skeie G, Lund E, Norat T, Gunter M, Riboli E, Brennan P.

BMC Med. 2016 Jun 14;14:87. doi: 10.1186/s12916-016-0630-6.

38.

Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.

Dietrich S, Floegel A, Weikert C, Prehn C, Adamski J, Pischon T, Boeing H, Drogan D.

Hypertension. 2016 Aug;68(2):471-7. doi: 10.1161/HYPERTENSIONAHA.116.07292. Epub 2016 May 31. Erratum in: Hypertension. 2016 Dec;68(6):e95.

PMID:
27245178
39.

Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study.

Aleksandrova K, di Giuseppe R, Isermann B, Biemann R, Schulze M, Wittenbecher C, Fritsche A, Lehmann R, Menzel J, Weikert C, Pischon T, Boeing H.

Cancer Res. 2016 Jul 1;76(13):3862-71. doi: 10.1158/0008-5472.CAN-15-3464. Epub 2016 May 23.

40.

Omentin-1, Adiponectin, and the Risk of Developing Type 2 Diabetes.

Wittenbecher C, Menzel J, Carstensen-Kirberg M, Biemann R, di Giuseppe R, Fritsche A, Isermann B, Herder C, Aleksandrova K, Boeing H, Weikert C, Schulze MB.

Diabetes Care. 2016 Jun;39(6):e79-80. doi: 10.2337/dc15-2702. Epub 2016 Apr 18. No abstract available.

PMID:
27208328
41.

Reproducibility of Retinol Binding Protein 4 and Omentin-1 Measurements over a Four Months Period: A Reliability Study in a Cohort of 207 Apparently Healthy Participants.

Wittenbecher C, di Giuseppe R, Biemann R, Menzel J, Arregui M, Hoffmann J, Aleksandrova K, Boeing H, Isermann B, Schulze MB, Weikert C.

PLoS One. 2015 Sep 24;10(9):e0138480. doi: 10.1371/journal.pone.0138480. eCollection 2015.

42.

Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study.

di Giuseppe R, Kühn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, Kaaks R, Boeing H, Stangl GI, Weikert C.

PLoS One. 2015 Jul 20;10(7):e0133580. doi: 10.1371/journal.pone.0133580. eCollection 2015.

43.

Physical Activity, Bone Health, and Obesity in Peri-/Pre- and Postmenopausal Women: Results from the EPIC-Potsdam Study.

Menzel J, di Giuseppe R, Wientzek A, Kroke A, Boeing H, Weikert C.

Calcif Tissue Int. 2015 Oct;97(4):376-84. doi: 10.1007/s00223-015-0027-0. Epub 2015 Jun 25.

44.

Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.

Jacobs S, Schiller K, Jansen E, Fritsche A, Weikert C, di Giuseppe R, Boeing H, Schulze MB, Kröger J.

Eur J Clin Nutr. 2015 May;69(5):642-6. doi: 10.1038/ejcn.2015.36. No abstract available.

PMID:
25944271
45.

Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.

Jäger S, Jacobs S, Kröger J, Stefan N, Fritsche A, Weikert C, Boeing H, Schulze MB.

PLoS One. 2015 Apr 22;10(4):e0124749. doi: 10.1371/journal.pone.0124749. eCollection 2015.

46.

Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.

di Giuseppe R, Kühn T, Hirche F, Buijsse B, Dierkes J, Fritsche A, Kaaks R, Boeing H, Stangl GI, Weikert C.

Eur J Epidemiol. 2015 Feb;30(2):131-41. doi: 10.1007/s10654-014-9982-4. Epub 2014 Dec 21.

PMID:
25527370
47.

Relationship between N-terminal pro-brain natriuretic peptide, obesity and the risk of heart failure in middle-aged German adults.

Wirth J, Buijsse B, di Giuseppe R, Fritsche A, Hense HW, Westphal S, Isermann B, Boeing H, Weikert C.

PLoS One. 2014 Nov 25;9(11):e113710. doi: 10.1371/journal.pone.0113710. eCollection 2014.

48.

The association between nut consumption and the risk of total and ischemic stroke in a German cohort study.

di Giuseppe R, Fjeld MK, Dierkes J, Theoflylaktopoulou D, Arregui M, Boeing H, Weikert C.

Eur J Clin Nutr. 2015 Apr;69(4):431-5. doi: 10.1038/ejcn.2014.212. Epub 2014 Oct 8.

PMID:
25293435
49.

Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study.

Jacobs S, Kröger J, Floegel A, Boeing H, Drogan D, Pischon T, Fritsche A, Prehn C, Adamski J, Isermann B, Weikert C, Schulze MB.

Am J Clin Nutr. 2014 Sep;100(3):891-900. doi: 10.3945/ajcn.113.080317. Epub 2014 Jul 23.

PMID:
25057154
50.

Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.

Holmes MV, Dale CE, Zuccolo L, Silverwood RJ, Guo Y, Ye Z, Prieto-Merino D, Dehghan A, Trompet S, Wong A, Cavadino A, Drogan D, Padmanabhan S, Li S, Yesupriya A, Leusink M, Sundstrom J, Hubacek JA, Pikhart H, Swerdlow DI, Panayiotou AG, Borinskaya SA, Finan C, Shah S, Kuchenbaecker KB, Shah T, Engmann J, Folkersen L, Eriksson P, Ricceri F, Melander O, Sacerdote C, Gamble DM, Rayaprolu S, Ross OA, McLachlan S, Vikhireva O, Sluijs I, Scott RA, Adamkova V, Flicker L, Bockxmeer FM, Power C, Marques-Vidal P, Meade T, Marmot MG, Ferro JM, Paulos-Pinheiro S, Humphries SE, Talmud PJ, Mateo Leach I, Verweij N, Linneberg A, Skaaby T, Doevendans PA, Cramer MJ, van der Harst P, Klungel OH, Dowling NF, Dominiczak AF, Kumari M, Nicolaides AN, Weikert C, Boeing H, Ebrahim S, Gaunt TR, Price JF, Lannfelt L, Peasey A, Kubinova R, Pajak A, Malyutina S, Voevoda MI, Tamosiunas A, Maitland-van der Zee AH, Norman PE, Hankey GJ, Bergmann MM, Hofman A, Franco OH, Cooper J, Palmen J, Spiering W, de Jong PA, Kuh D, Hardy R, Uitterlinden AG, Ikram MA, Ford I, Hyppönen E, Almeida OP, Wareham NJ, Khaw KT, Hamsten A, Husemoen LL, Tjønneland A, Tolstrup JS, Rimm E, Beulens JW, Verschuren WM, Onland-Moret NC, Hofker MH, Wannamethee SG, Whincup PH, Morris R, Vicente AM, Watkins H, Farrall M, Jukema JW, Meschia J, Cupples LA, Sharp SJ, Fornage M, Kooperberg C, LaCroix AZ, Dai JY, Lanktree MB, Siscovick DS, Jorgenson E, Spring B, Coresh J, Li YR, Buxbaum SG, Schreiner PJ, Ellison RC, Tsai MY, Patel SR, Redline S, Johnson AD, Hoogeveen RC, Hakonarson H, Rotter JI, Boerwinkle E, de Bakker PI, Kivimaki M, Asselbergs FW, Sattar N, Lawlor DA, Whittaker J, Davey Smith G, Mukamal K, Psaty BM, Wilson JG, Lange LA, Hamidovic A, Hingorani AD, Nordestgaard BG, Bobak M, Leon DA, Langenberg C, Palmer TM, Reiner AP, Keating BJ, Dudbridge F, Casas JP; InterAct Consortium.

BMJ. 2014 Jul 10;349:g4164. doi: 10.1136/bmj.g4164.

Supplemental Content

Loading ...
Support Center